CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
$4.76 -0.21 (-4.2254%)
Analysed CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) News Sources
CVKD: Results Show 12-LOX Inhibition Targets Inflammation from Obesity and Type 2 Diabetes
08-04-2026
yahoo.com
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting
31-03-2026
yahoo.com
OTC Markets Hosts Virtual Investor Presentation with Quang Pham, Chairman and CEO of Cadrenal Therapeutics, and David Bautz, PhD, Senior Analyst at Zacks SCR
20-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
13-03-2026
yahoo.com
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
12-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
10-03-2026
yahoo.com
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
02-03-2026
yahoo.com
CVKD: Phase 2 HIT Results Show Encouraging Reduction in Thrombotic Events
25-02-2026
yahoo.com
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
24-02-2026
yahoo.com
CVKD: Acquires 12-LOX Inhibitor for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
20-02-2026
yahoo.com
What is the current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is $4.76.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is $-0.21.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is -4.2254%.
What is the most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is .
SEC-8K** Filing Available For CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.